Literature DB >> 25303530

Enhancer activation requires trans-recruitment of a mega transcription factor complex.

Zhijie Liu1, Daria Merkurjev2, Feng Yang3, Wenbo Li3, Soohwan Oh4, Meyer J Friedman3, Xiaoyuan Song5, Feng Zhang3, Qi Ma2, Kenneth A Ohgi3, Anna Krones3, Michael G Rosenfeld6.   

Abstract

Enhancers provide critical information directing cell-type-specific transcriptional programs, regulated by binding of signal-dependent transcription factors and their associated cofactors. Here, we report that the most strongly activated estrogen (E2)-responsive enhancers are characterized by trans-recruitment and in situ assembly of a large 1-2 MDa complex of diverse DNA-binding transcription factors by ERα at ERE-containing enhancers. We refer to enhancers recruiting these factors as mega transcription factor-bound in trans (MegaTrans) enhancers. The MegaTrans complex is a signature of the most potent functional enhancers and is required for activation of enhancer RNA transcription and recruitment of coactivators, including p300 and Med1. The MegaTrans complex functions, in part, by recruiting specific enzymatic machinery, exemplified by DNA-dependent protein kinase. Thus, MegaTrans-containing enhancers represent a cohort of functional enhancers that mediate a broad and important transcriptional program and provide a molecular explanation for transcription factor clustering and hotspots noted in the genome.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25303530      PMCID: PMC4465761          DOI: 10.1016/j.cell.2014.08.027

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  37 in total

Review 1.  Structure and evolution of transcriptional regulatory networks.

Authors:  M Madan Babu; Nicholas M Luscombe; L Aravind; Mark Gerstein; Sarah A Teichmann
Journal:  Curr Opin Struct Biol       Date:  2004-06       Impact factor: 6.809

2.  A transcription factor collective defines cardiac cell fate and reflects lineage history.

Authors:  Guillaume Junion; Mikhail Spivakov; Charles Girardot; Martina Braun; E Hilary Gustafson; Ewan Birney; Eileen E M Furlong
Journal:  Cell       Date:  2012-02-03       Impact factor: 41.582

3.  Genomic antagonism between retinoic acid and estrogen signaling in breast cancer.

Authors:  Sujun Hua; Ralf Kittler; Kevin P White
Journal:  Cell       Date:  2009-06-26       Impact factor: 41.582

4.  DNA-dependent protein kinase catalytic subunit: a relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product.

Authors:  K O Hartley; D Gell; G C Smith; H Zhang; N Divecha; M A Connelly; A Admon; S P Lees-Miller; C W Anderson; S P Jackson
Journal:  Cell       Date:  1995-09-08       Impact factor: 41.582

5.  Genome-wide analysis of estrogen receptor alpha DNA binding and tethering mechanisms identifies Runx1 as a novel tethering factor in receptor-mediated transcriptional activation.

Authors:  Joshua D Stender; Kyuri Kim; Tze Howe Charn; Barry Komm; Ken C N Chang; W Lee Kraus; Christopher Benner; Christopher K Glass; Benita S Katzenellenbogen
Journal:  Mol Cell Biol       Date:  2010-06-14       Impact factor: 4.272

6.  Histone modifications at human enhancers reflect global cell-type-specific gene expression.

Authors:  Nathaniel D Heintzman; Gary C Hon; R David Hawkins; Pouya Kheradpour; Alexander Stark; Lindsey F Harp; Zhen Ye; Leonard K Lee; Rhona K Stuart; Christina W Ching; Keith A Ching; Jessica E Antosiewicz-Bourget; Hui Liu; Xinmin Zhang; Roland D Green; Victor V Lobanenkov; Ron Stewart; James A Thomson; Gregory E Crawford; Manolis Kellis; Bing Ren
Journal:  Nature       Date:  2009-03-18       Impact factor: 49.962

7.  Combinatorial transcriptional control in blood stem/progenitor cells: genome-wide analysis of ten major transcriptional regulators.

Authors:  Nicola K Wilson; Samuel D Foster; Xiaonan Wang; Kathy Knezevic; Judith Schütte; Polynikis Kaimakis; Paulina M Chilarska; Sarah Kinston; Willem H Ouwehand; Elaine Dzierzak; John E Pimanda; Marella F T R de Bruijn; Berthold Göttgens
Journal:  Cell Stem Cell       Date:  2010-10-08       Impact factor: 24.633

8.  Molecular architecture of transcription factor hotspots in early adipogenesis.

Authors:  Rasmus Siersbæk; Songjoon Baek; Atefeh Rabiee; Ronni Nielsen; Sofie Traynor; Nicholas Clark; Albin Sandelin; Ole N Jensen; Myong-Hee Sung; Gordon L Hager; Susanne Mandrup
Journal:  Cell Rep       Date:  2014-05-22       Impact factor: 9.423

9.  Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor.

Authors:  Hisham Mohammed; Clive D'Santos; Aurelien A Serandour; H Raza Ali; Gordon D Brown; Alan Atkins; Oscar M Rueda; Kelly A Holmes; Vasiliki Theodorou; Jessica L L Robinson; Wilbert Zwart; Amel Saadi; Caryn S Ross-Innes; Suet-Feung Chin; Suraj Menon; John Stingl; Carlo Palmieri; Carlos Caldas; Jason S Carroll
Journal:  Cell Rep       Date:  2013-02-09       Impact factor: 9.423

10.  GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility.

Authors:  Vasiliki Theodorou; Rory Stark; Suraj Menon; Jason S Carroll
Journal:  Genome Res       Date:  2012-11-21       Impact factor: 9.043

View more
  89 in total

Review 1.  Genome-Wide Approaches to Defining Macrophage Identity and Function.

Authors:  Gregory J Fonseca; Jason S Seidman; Christopher K Glass
Journal:  Microbiol Spectr       Date:  2016-10

Review 2.  Estrogens regulate life and death in mitochondria.

Authors:  Carolyn M Klinge
Journal:  J Bioenerg Biomembr       Date:  2017-08       Impact factor: 2.945

3.  Meta-analysis of Chromatin Programming by Steroid Receptors.

Authors:  Ville Paakinaho; Erin E Swinstead; Diego M Presman; Lars Grøntved; Gordon L Hager
Journal:  Cell Rep       Date:  2019-09-24       Impact factor: 9.423

Review 4.  Regulatory states in the developmental control of gene expression.

Authors:  Isabelle S Peter
Journal:  Brief Funct Genomics       Date:  2017-09-01       Impact factor: 4.241

5.  Phase separation of ligand-activated enhancers licenses cooperative chromosomal enhancer assembly.

Authors:  Sreejith J Nair; Lu Yang; Dario Meluzzi; Soohwan Oh; Feng Yang; Meyer J Friedman; Susan Wang; Tom Suter; Ibraheem Alshareedah; Amir Gamliel; Qi Ma; Jie Zhang; Yiren Hu; Yuliang Tan; Kenneth A Ohgi; Ranveer Singh Jayani; Priya R Banerjee; Aneel K Aggarwal; Michael G Rosenfeld
Journal:  Nat Struct Mol Biol       Date:  2019-03-04       Impact factor: 15.369

6.  CDK7 Inhibition Suppresses Castration-Resistant Prostate Cancer through MED1 Inactivation.

Authors:  Reyaz Ur Rasool; Ramakrishnan Natesan; Qu Deng; Shweta Aras; Priti Lal; Samuel Sander Effron; Erick Mitchell-Velasquez; Jessica M Posimo; Shannon Carskadon; Sylvan C Baca; Mark M Pomerantz; Javed Siddiqui; Lauren E Schwartz; Daniel J Lee; Nallasivam Palanisamy; Goutham Narla; Robert B Den; Matthew L Freedman; Donita C Brady; Irfan A Asangani
Journal:  Cancer Discov       Date:  2019-08-29       Impact factor: 39.397

7.  Differential effects of HTLV-1 Tax oncoprotein on the different estrogen-induced-ER α-mediated transcriptional activities.

Authors:  Ammar Abou-Kandil; Nora Eisa; Azhar Jabareen; Mahmoud Huleihel
Journal:  Cell Cycle       Date:  2016-07-15       Impact factor: 4.534

8.  The Phosphorylated Estrogen Receptor α (ER) Cistrome Identifies a Subset of Active Enhancers Enriched for Direct ER-DNA Binding and the Transcription Factor GRHL2.

Authors:  Kyle T Helzer; Mary Szatkowski Ozers; Mark B Meyer; Nancy A Benkusky; Natalia Solodin; Rebecca M Reese; Christopher L Warren; J Wesley Pike; Elaine T Alarid
Journal:  Mol Cell Biol       Date:  2019-01-16       Impact factor: 4.272

9.  RhoA inhibits neural differentiation in murine stem cells through multiple mechanisms.

Authors:  Junning Yang; Chuanshen Wu; Ioana Stefanescu; Lars Jakobsson; Inna Chervoneva; Arie Horowitz
Journal:  Sci Signal       Date:  2016-07-26       Impact factor: 8.192

10.  Pan-cancer analyses of the nuclear receptor superfamily.

Authors:  Mark D Long; Moray J Campbell
Journal:  Nucl Receptor Res       Date:  2015-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.